Optimization of RP-HPLC Method for Simultaneous Estimation of Lamivudine and Raltegravir in Binary Mixture by Using Design of Experiment
 
More details
Hide details
1
Pt. Ravishankar Shukla University, INDIA
CORRESPONDING AUTHOR
Veena D. Singh   

University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, India
Online publish date: 2016-12-15
Publish date: 2016-12-15
 
Eurasian J Anal Chem 2017;12(3):179–195
KEYWORDS
TOPICS
ABSTRACT
A simple, sensitive, cost effective and robust RP-HPLC method for the simultaneous estimation of the Lamivudine (LAM) and Raltegravir (RAL) in laboratory prepared binary mixture was developed, optimized and validated. Separation was achieved on phenomenex C18 column (150 X 4.6 mm id, 5μ particle size) and mobile phase was composed of 75% methanol: 15% Acetonitril: 10 % (0.05mM) phosphate buffer (at pH 3.0), with flow rate 1.2 ml/min at 254nm. Developed method was optimized by using Box Behnken Design (BBD) in response surface methodology (RSM). The independent variables such as the concentration of methanol, pH in mobile phase and flow rate were selected for the optimization and Retention time (Rt) were used as responses for both drugs. Derringer’s desirability function was used to concurrently optimize the selected responses. The LOD and LOQ were found to be 1.04 and 3.18 μg/ mL for LAM and 0.36 and 1.08μg/mL of RAL. The percentage recoveries were found to be less than 2% for LAM and RAL. Retention time of LAM and RAL was 3.13±0.07 and 7.27±0.01 minutes respectively. Conclusion: The developed and optimized method was fully validated. The validated method further can be potentially used for estimation of these drugs in combined dosage form.
 
REFERENCES (47)
2.
Nandimandalam, H. & Gowri Sankar, D. (2015). Simultaneous RP-HPLC method development and validation for Lamivudine & Raltegravir in bulk API dosage forms. American Journal of Pharm Tech Research, 5(5), 249-256.
 
3.
Sockalingam, A., Narayanareddy, I., Shanmugapandiyan, P, & Seshaiah, K. S. (2005). Simultaneous quantification of Stavudine, Lamivudine and Nevirapine by UV spectroscopy, reverse phase HPLC and HPTLC in tablets. Journal of Pharmaceutical and Biomedical Analysis, 39(3-4), 801–804.
 
4.
Deepali, G., & Elvis, M. (2010). UV spectrophotometric method for assay of the anti-retroviral agent Lamivudine in active pharmaceutical ingredient and in its tablet formulation. Journal of young pharmacist, 2(4), 417-419.
 
5.
Karunakaran, A., Kamarajan, K., & Thangarasu, V. (2010). Development and validation of first-derivative spectrophotometric method for the simultaneous estimation of Lamivudine and Tenofovir disoproxil fumerate in pure and in tablet formulation. Der Pharmacia Lettre, 2(5), 221-228.
 
6.
Manikanta, K. A., Sandhya, B. N., Nasare, M., Prasad, V. V. L. N, & Diwan, P. V. (2012). Development and validation of UV Spectrophotometric method for simultaneous estimation of Lamivudine and Efavirenz in the Pharmaceutical dosage form. Journal of Advanced Pharmaceutical Technology & Research 2(4), 210-214.
 
7.
Baig, M. V., Kapse, G. S., & Raju, S. A. (2001). Spectrophotometric Determination of Lamivudine. Asian Journal of Chemistry, 13, 185–189.
 
8.
Appalaraju, S., Karadi, A. B., Kamalapurkar, G. S., & Sarasambi, P. S. (2002). Spectrophotometric determination of Lamivudine. Asian Journal of Chemistry, 14, 475–8.
 
9.
Shalini, S., Shanooja, V. P., Jameel, S. A., Harilal, K. K., Rajak, H., & Ravichandran, V. (2009). Application of UV-spectrophotometric methods for estimation of lamivudine in tablets. Digest Journal of Nanomaterials & Biostructures, 4(2), 357–60.
 
10.
Rajesh, P. V., Karunasree, C. P., Dharmamoorthy, G., Padmini, K., & Sudeer, C. H. (2012). Development and partial validation of the Lamivudine drug in bulk and solid dosage form by UV spectroscopy. International Journal of Pharmaceutical Development & Technology, 2(1), 15-19.
 
11.
Bahrami, G., Mirzaeei, S., Kiani, A., & Mohammadi, B. (2005). High- performance liquid chromatographic determination of Lamuvidine in human serum using liquid-liquid extraction; application to pharmacokinetic studies. Journal of Chromatography B, 823(2), 213-217.
 
12.
Sibel, A. O., & Bengi, U. (2002). Rapid HPLC assay for Lamuvidine in pharmaceutical and human serum. Journal of Liquid Chromatography & Related Technologies, 25(9), 1447-1456.
 
13.
Kano, E. K., dos Reis Serra, C. H., Koono, E. E. M., & Schramm, S. (2006). Determination of Lamuvidine in human plasma by HPLC and its use in bioequivalence studies. Journal of Pharmaceutical and Biomedical Analysis, 4(3), 761-765.
 
14.
Vanaja, P., Anusha, N., & Giri Prasad, V. S. (2013). Development and validation of RP-HPLC method for the simultaneous estimation of Tenofovir disproxil fumerate and Lamuvidine in combined dosage form. International Journal of Pharmacy and Pharmaceutical Sciences, 5(3), 116-121.
 
15.
Chopperla, S. K., Vijay Kumar, B., & Gouri Shankar, D. (2013). Method development and validation of RP-HPLC method for the simultaneous estimation of tenofovir disproxil fumerate and Lamuvidine in combined dosage form. International Journal of Pharmaceutical Research and Development, 4 (11), 110-118.
 
16.
Krishnareddy, N. V., Phani, R. S., & Ramesh, R. R. (2011). New RP - HPLC Method Development for Analysis and Assay of Lamivudine in Formulation. International Journal of Research in Pharmaceutical and Biomedical Sciences, 2(1), 220-223.
 
17.
Verweijvan Wissen, C. P., Aarnoutse, R. E., & Burger, D. M. (2005). Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors Lamivudine, Didanosine, Stavudine, Zidovudine and Abacavir in human plasma by reversed phase high performance liquid chromatography. Journal of Chromatography. B, 816(1-2), 121–129.
 
18.
Habte, G., Hymete, A., & Mohamed, A. M. I. (2009). Simultaneous separation and determination of Lamivudine and Zidovudine in pharmaceutical formulations using the HPTLC method. Analytical. Letters, 42, 1552–1570.
 
19.
Balaji, M., Srikanth, R., Ashok Kumar, V., Ulaganathan, C., & Muneer, S. (2011). Method development and validation of HPTLC method for quantitative estimation of Tenofovir disproxil fumerate and Lamuvidine in combined dosage form. International Journal of Pharmaceutical Research and Development, 4(6), 23-29.
 
20.
Pereira, S. A. S., Kenney, K. B., & Cohen, M. S. (2000). Simultaneous determination of Lamivudine and Zidovudine concentrations in human plasma using high-performance liquid chromatography and tandem mass spectrometry. Journal of Chromatography. B, 742, 173–183.
 
21.
Brian, L., Robbins, A., Philip, F., & Erin, F. (2007). Simultaneous measurement of intracellular triphosphate metabolites of zidovudine, Lamivudine and Abacavir (Carbovir) in human peripheral blood mononuclear cells by LC–MS. Journal of Chromatography. B, 850, 310–317.
 
22.
Kore, P. P., Gamepatil, M. M., Nimje, H. M., & Baheti, K. G. (2014). Spectrophotometric estimation of Raltegravir potassium in tablets. Indian Journal of Pharmaceutical Sciences, 76, 557-559.
 
23.
Sudha, T., & Raghupathi, T. (2011). RP-HPLC and UV spectrophotometeric method for estimation of Raltegravir Potassium in bulk and tablet dosage form. Global Journal Medical Reseach, 11, 9-15.
 
24.
Siddartha, B., & Sudheer, I. (2014), UV – Spectrophotometric method for estimation of Raltegravir in bulk and tablet dosage form. International Journal of Pharmaceutical, Chemical and Biological Sciences, 4(4), 807-811.
 
25.
Bhavar, G.B., Pekamwar, S. S., Aher, K. B., & Chaudhari, S. R. (2013). Simple Spectrophotometric Method for Estimation of Raltegravir Potassium in Bulk and Pharmaceutical formulations. Journal of Applied Pharmaceutical Sciences, 3(10), 147- 150.
 
26.
Satyanarayana, L., Naidu, S.V., Narasimha, R. M., Ayyanna, C., & Alok, K. (2011). Estimation of Raltegravir in tablet dosage form by RP-HPLC. Asian Journal of Pharmaceutical Analysis, 1(3), 56-58.
 
27.
Nicastri, E., Bellagamba, R., Tempestilli, M., Pucillo, L. P., Narciso, P., & Ascenzi, P. (2009). Simultaneous Determination of Maraviroc and Raltegravir in human plasma by HPLC-UV method. International Union of Biochemistry and Molecular Biology, 61(4), 470-475.
 
28.
Sudha, T., & Raghupathi, T. (2011). Reverse Phase–High Performance Liquid Chromatography and Ultra Violet Spetrophotometric Method for the Estimation of Raltegravir Potassium in Bulk and in Tablet Dosage Form. Global Journal of Medical Research, 11(2), 8-16.
 
29.
Lakshamana Rao, A., & Raghu Ram, M. S. (2012). Validated Reverse Phase HPLC Method for Determination of Raltegravir in Pharmaceutical Preparation. International Journal of Research in Pharmacy and Chemistry, 2(1), 217-221.
 
30.
D’Avolio, A., Baietto, L., Siccardi, M., Simiele, M., Oddone, V., Bonora, S., & Di Perri, G. (2008). An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor Raltegravir, the new nucleoside reverse transcriptase inhibitor Etravirine, and 11 other antiretroviral agents in the plasma of HIV infected patients. Therapeutic Drug Monitoring, 30(6), 662-669.
 
31.
Rezk, N. L., White, N., & Kashuba, A. D. (2008). An Accurate and Precise High Performance Liquid Chromatography method for the rapid quantification of the novel HIV integrase inhibitor Raltegravir in human blood plasma after solid phase extraction. Analytica Chimica Acta, 628(2), 204-213.
 
32.
Rami Reddy, B. V., Reddy, B. S., Raman, N. V. V. S. S., Jyothi, G., Subhash Chander Reddy, K., & Rambabu, C. (2012). Validated stability-indicating UPLC assay method and degradation behavior of Raltegravir Potassium. International Journal of Pharmacy and Technology, 4(1), 4045-4059.
 
33.
Merschman, S.A., Vallano, P. T., Wenning, L. A., Matuszewki, B. K., & Woolf, E. J. (2007). Determination of the HIV integrase inhibitor MK- 0518(Raltegravir) in the human plasma using 96-well liquid-liquid extraction and HPLC-MS/MS. Journal of Chromatography B Analytical Technology and Biomedical Life Sciences, 857(1), 15-24.
 
34.
Long, M. C., Bennetto-Hood, C., & Acosta, E. P. (2008). A sensitive HPLC-MS-MS Method for the determination of Raltegravir in the human plasma. Journal of Chromatography B Analytical Technology and Biomedical Life Sciences, 867(2), 165-71.
 
35.
Sudha, T., & Shanmugasundram, P. (2011). Development and validation of RP-HPLC and HPTLC chromatographic method of analysis for the quantitative estimation of Raltegravir Potassium in Pharmaceutical dosage form. Research Journal of Pharmacy and Technology 4(11), 1746-1750.
 
36.
ICH Q2 (R1) Guideline, Validation of Analytical Procedures, Text and Methodology. (2005). ICH, Geneva, Switzerland.
 
37.
Valliappan, K., Kannan, K., Manavalan, R., & Muralidharan, C. (2002). Application of chemometrics in chromatography. Indian Journal of Chemistry, 41(A), 7.
 
38.
Myers, R. H. & Montgomery, D. C. (2002). Response surface methodology process and product optimization using designed experiments. John Wiley & Sons, Inc, 2nd ed., New-York, USA.
 
39.
Sivakumar, T., Manavalan, R., Muralidharan, C., & Valliappan , K. (2007). Multicriteria,decision making approach and experimental design as chemometric tools to optimize HPLC separation of domperidone and pantoprazole. Journal of Pharmaceutical and Biomedical Analysis, 43(5), 1842–1848.
 
40.
Monks, K., Molnár, I., Rieger, H. J., Bogáti, B., & Szabó, E. (2012). Quality by Design, Multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation. Journal of Chromatography A, 1232, 218-230.
 
41.
Beg, S., Kohli, K., Swain, S., & Hasnain, M. S. (2011). Development and validation of RP-HPLC method for quantitation of amoxicillin trihydrate in bulk and pharmaceutical formulations using Box-Behnken experimental design. Journal of Liquid Chromatography and Related Technologies, 35, 393–406.
 
42.
Rozet, E., Ziemons, E., Marini, R. D., Boulanger, B., & Hubert, P. (2012). Quality by design compliant analytical method validation. Analytical Chemistry, 84, 106-112.
 
43.
Nethercote, P., & Ermer, J. (2012). Quality by design for analytical methods, implications for method validation and transfer. Pharmaceutical Technology, 36, 74–79.
 
44.
Harang, V., Karlsson, A., & Josefson, M. (2001). Liquid chromatography method development and optimization by statistical experimental design and chromatogram simulations. Chromatographia, 54, 703.
 
45.
Manish, S., Kanchan, K., & Mushir, A. (2016). Stability Indicating RP-HPLC Method for Analysis of Ketoprofen in Bulk Drug and Eugenol Containing Nanoemulsion Gel (NEG) Formulation Using Response Surface Methodology. Current Pharmaceutical Analysis, 10(2), 135-144.
 
46.
Kumar, N. S., Kumaraswamy, R., Paul, D. (2015). QbD Based RP-HPLC Method for Screening and Analysis of Telapravir & 7 Other Antiretroviral Agents. Indian Drugs, 52(2), 20-30.
 
47.
Shrikant, P., Vijayakrishna, K., & Jaiprakash, S. (2016). Quality by Design (QbD) approach towards the development and validation of HPLC method for Gentamicin content in biodegradable implants. Der Pharma Chemica, 8(1), 282-288.
 
eISSN:1306-3057